Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | S.A PHARMACEUTICALSLikely | - | 1 | ₹98,560 |
| 2 | Schedule 2 | - | - | - | - |
| 3 | Schedule 3 | SONDHI SONS PHARMALikely | - | 1 | ₹55,110 |
| 4 | Schedule 4 | - | - | - | - |
| 5 | Schedule 5 | SONDHI SONS PHARMALikely | - | 1 | ₹80,496 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
18 Jan 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
GABAPENTIN 300MG TAB slash CAP
DUTASTERIDE 0 point 5 MG TAB
PANTOPRAZOLE 40 MG plus ITOPRIDE 150 MG CAP
TORSEMIDE 20 MG TAB
AMOXYCILLIN 500 MG plus CLAVULINIC ACID 125 MG TAB
ALPHA LIPOIC ACID plus CHROMIUM plus FOLIC ACID METHYLCOBALAMIN plus SELENIUM plus ZINC
MONTELUKAST 10 MG TAB
METOPROLOL XL 12 point 5 MG TAB
THYROXIN 100 MCG TAB
GLUCOSAMINE 500 MG plus DIACERIN 50 MG TAB
ASPIRIN 75 MG plus ATORVASTATIN 10 MG TAB
METHYLCOBALAMIN 1500MCG plus ALPHA LIPOIC ACID 100MG plus MYO INOSITOL 100MG plus FOLIC ACID 1 point 5 MG plus CHROMIUM PICOLINATE 200 MCG plus SELENIUM 55 MCG plus BENFOTIAMINE 150 MG CAP
BISOPROLOL 2 point 5MG TAB
PIOGLITAZONE 15 MG TAB
HYDROCHLOROTHIAZIDE 12 point 5 MG TAB
PHENYTOIN SODIUM 100 MG
S AMLODIPINE 2 point 5 MGTAB
METFORMIN 1000 MG TAB
GLICLAZIDE 40 MG TAB
DULOXETINE 20MG CAP
SIMVASTATIN 20 MG TAB
ESCITALOPRAM 10 MG TAB
GLUCOSAMINE 500 MG TAB
LINAGLIPTIN 5 MG TAB
GLUCOSAMINE 500 MG plus CHONDRIOTIN 400 MG TAB
ETORICOXCIB 120 MG TAB
DICLOFENAC SODIUM 100 MG SR TAB
RAMIPRIL 2 point 5 MG TAB
ISOSORBID MONONITRATE 20 MG TAB
CARBIDOPA 25 MG plus LEVODOPA 100 MG CR TAB
RANOLAZINE 500 MG TAB
BETAHISTINE 16 MG TAB
GLICLAZIDE 30 MG MR TAB
PIRACETAM 400 MG TAB
PRAZOSIN SR 5 MG TAB Bid Number ( ) : GEM/2024/B/5696594 Dated : 28-12-2024 Bid Document 1/33
7237627
GEM/2024/B/5696594
Two Packet Bid
GABAPENTIN 300MG TAB slash CAP
23 days
Haryana; Jalandhar, Punjab; Jalandhar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
80%
Exempted
18 Jan 2025
28 Dec 2024
18 Jan 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | GABAPENTIN 300MG TAB slash CAP | 1,76,000 | No | JALANDHAR CITY | 28 |
| 2 | DUTASTERIDE 0 point 5 MG TAB | 1,70,540 | No | JALANDHAR CITY | 28 |
| 3 | PANTOPRAZOLE 40 MG plus ITOPRIDE 150 MG CAP | 1,67,000 | No | JALANDHAR CITY | 28 |
| 4 | TORSEMIDE 20 MG TAB | 1,15,100 | No | JALANDHAR CITY | 28 |
| 5 | AMOXYCILLIN 500 MG plus CLAVULINIC ACID 125 MG TAB | 1,54,800 | No | JALANDHAR CITY | 28 |
| 6 | ALPHA LIPOIC ACID plus CHROMIUM plus FOLIC ACID METHYLCOBALAMIN plus SELENIUM plus ZINC | 1,53,000 | No | JALANDHAR CITY | 28 |
| 7 | MONTELUKAST 10 MG TAB | 1,53,000 | No | JALANDHAR CITY | 28 |
| 8 | METOPROLOL XL 12 point 5 MG TAB | 1,52,000 | No | JALANDHAR CITY | 28 |
| 9 | THYROXIN 100 MCG TAB | 1,28,200 | No | JALANDHAR CITY | 28 |
| 10 | GLUCOSAMINE 500 MG plus DIACERIN 50 MG TAB | 1,17,000 | No | JALANDHAR CITY | 28 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7237627.pdf
GEM_BID
echs_re_130_noting_sample_2024-12-12-11-32-29_2cc6e95516a286ec45a072f74e23293a.pdf
BOQ
boq_item_sample_file-2_2024-12-12-11-32-29_2edad3283d7efcfddbb9bb8996ee6b69.csv
BOQ
ATC_b122819c-e462-45f2-96cf1733984196257_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .